Test Drug Shows Mixed Results in Heart Patients
Each year, about a million Americans are hospitalized with heart failure. A new drug may make those patients more comfortable more quickly, but a new study shows its benefits are limited.Posted — Updated
Gary Larocque said he will never forget being in the hospital with heart failure.
A worldwide study tested a new drug called Tolvaptan. The drug slows a hormone that causes the body to hold onto fluid during heart failure.
"But at the same time, we didn't see any evidence that it hastened death or that it reduced survival," Konstam said.
Many heart-failure patients currently receive diuretics to treat fluid build-up, but that medication doesn't work for everyone and it can be hard on the kidneys. The study showed Tolvaptan did not affect the kidneys.
The maker of Tolvaptan funded the study.
Copyright 2023 by Capitol Broadcasting Company. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.